We again see that here
The promise is compelling: access to medications containing compounded formulations of the active ingredient as Wegovy, Ozempic, Mounjaro, and Zepbound, often at a fraction of the brand-name cost
More specifically, the FDA label states that these medications may lead to thyroid C-cell tumors
step therapy required BCBS of Illinois Covered with PA BMI criteria + documented diet/exercise failure BCBS of Michigan Not covered (fully insured) Removed all GLP-1 weight loss drugs from commercial plans Jan 2025 BCBS of Florida (Florida Blue) Covered with PA BMI 30
By reducing appetite, slowing gastric emptying, and improving insulin sensitivity, patients can achieve meaningful weight loss, although results may vary based on diet, physical activity, and adherence to treatment
From there, regular provider check-ins are available to fine-tune your plan over time